Cissampelos sympodialis Eichler, Menispermaceae, a Brazilian medicinal plant and its alkaloid warifteine present immunomodulatory activity on asthma experimental model by reducing antigen-specific IgE levels, eosinophil infiltration and lung hyperactivity. Allergic rhinitis is a chronic inflammatory disorder of the nasal tissue that affect the quality of life and it is a risk factor for asthma exacerbation. This study evaluated the effect of inhaled warifteine in an allergic ovalbumin rhinitis model. Inhaled warifteine (2 mg/ml) treatment of ovalbumin-sensitized BALB/c mice significant decreased total and differential number of cells on the nasal cavity and decreased ovalbumin-specific IgE serum levels. Hematoxylin & eosin staining of histological preparations of ovalbumin nasal tissues showed changes such as congestion and a massive cell infiltration in the perivascular and subepithelial regions characterizing the nasal inflammatory process. However, inhaled warifteine or dexamethasone treatment decreased cell infiltration into the perivascular regions and it was observed an intact nasal tissue. Periodic acidic staining of nasal epithelium of ovalbumin animals demonstrated high amount of mucus production by goblet cells and inhaled warifteine or dexamethasone treatment modulated the mucus production. In addition, toluidine blue staining of the nasal epithelium of ovalbumin animals demonstrated an increase of mast cells on the tissue and inhaled warifteine or dexamethasone treatment decreased in average of 1.4 times the number of these cells on the nasal epithelium. Taken these data together we postulate that warifteine, an immunomodulatory alkaloid, can be a medicinal molecule prototype to ameliorate the allergic rhinitis conditions.
Barbosa-Filho, J.M., Agra, N.F., Thomas, G., 1997. Botanical, chemical and pharmacological investigation on Cissampelos species from Paraíba (Brazil). Ciênc Cult. 49, 386–394.
Barbosa-Filho, J., Vasconcelos, L.C.E., Gray, A.I., 2000. Alkaloids of the Menisperma-ceae. Alkaloids Chem. Biol. 54, 1–190.
Barnes, P.J., 1999. Therapeutic strategies for allergic diseases. Nature 402, 676–678.
Bentley, A.M., Meng, Q., Robinson, D.S., Hamid, Q., Kay, A.B., Durham, S.R., 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 18, 35–42.
Bezerra-Santos, C.R., Vieira-De-Abreu, A., Vieira, G.C., Filho, J.R., Barbosa-Filho, J.M., Pires, A.L., 2012. Effectiveness of Cissampelos sympodialis and its isolated alkaloid warifteine in airway hyperreactivity and lung remodeling in a mouse model of asthma. Int. Immunopharmacol. 13, 148–155.
Bezerra-Santos, C.R., Vieira-de-Abreu, A., Barbosa-Filho, J.M., Bandeira-Melo, C., Piuvezam, M.R., Bozza, P.T., 2006. Anti-allergic properties of Cissampelos sympodialis and its isolated alkaloid warifteine. Int. Immunopharmacol. 6, 1152–1160.
Bezerra-Santos, C.R., Balestieri, F.M.P., Rossi-Bergmann, B., Pecanha, L.M.T., Piuvezam, M.R., 2004. Cissampelos sympodialis Eichl. (Menispermaceae): oral treatment decreases IgE levels and induces a Th1-skewed cytokine production in ovalbumin-sensitized mice. J. Ethnopharmacol. 95, 191–197.
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J.E., 2008. Allergic rhinitis and its impact. Eur. J. Allergy Clin. Immunol. 63, 86–93.
Broide, D.H., Finkelman, F., Bochner, B.S., Rothenberg, M.E., 2011. Advances in mechanisms of asthma, allergy, and immunology in 2010. J. Allergy Clin. Immunol. 127, 689–695.
Cerqueira-Lima, A.T., Alcântara-Neves, N.M., de Carvalho, L.C.P., Costa, R.S., Barbosa-Filho, J.M., Piuvezam, M., 2010. Effects of Cissampelos sympodialis Eichl. and its alkaloid, warifteine, in an experimental model of respiratory allergy to Blomia tropicalis. Curr. Drug Targets 11, 1458–1467.
Compalati, E., Ridolo, E., Passalacqua, G., Braido, F., Villa, E., Canonica, G.W., 2010. The link between allergic rhinitis and asthma: the united airways disease. Expert Rev. Clin. Immunol. 6, 413–423.
Costa, H.F., Bezerra-Santos, C.R., Barbosa Filho, J.M., Martins, M.A., Piuvezam, M.R., 2008. Warifteine, a bisbenzylisoquinoline alkaloid, decreases immediate allergic and thermal hyperalgesic reactions in sensitized animals. Int. Immunopharmacol. 8, 916–925.
De Freitas, M.R., Côrtest, S.D.F., Thomas, G., Barbosa Filho, J.M., 1996. Modification of Ca2+ metabolism in the rabbit aorta as a mechanism of spasmolytic action of warifteine, a bisbenzylisoquinoline alkaloid isolated from the leaves of Cissampelos sympodialis Eichl. (Menispermaceae). J. Pharm. Pharmacol. 48, 332–338.
Galli, S.J., Tsai, M., 2012. IgE and mast cells in allergic disease. Nat. Med. 18, 693–704.
Han, D., Liu, S., Zhang, Y., Wang, J., Wang, D., Kong, W., 2011. Efficacy and safety of fluticasone furoate nasal spray in Chinese adult and adolescent subjects with intermittent or persistent allergic rhinitis. Allergy Asthma Proc. 32, 472–481.
Holgate, S.T., Polosa, R., 2008. Treatment strategies for allergy and asthma. Nat. Rev. Immunol. 8, 218–230.
Holt, P.G., Britten, D., Sedgwick, J.D., 1987. Suppression of IgE responses by antigen inhalation: studies on the role of genetic and environmental factors. Immunology 60, 97–102.
Mandhane, S.N., Shah, J.H., Thennati, R., 2011. Allergic rhinitis: an update on disease, present treatments and future prospects. Int. Immunopharmacol. 11, 1646–1662.
Palm, N.W., Rosenstein, R.K., Medzhitov, R., 2012. Allergic host defences. Nature 484, 465–472.
Ribeiro-Filho, J., Calheiros, A.S., Vieira-de-Abreu, A., de Carvalho, K.I.M., da Silva, M.D., Melo, C.B., 2013. Curine inhibits eosinophil activation and airway hyper-responsiveness in a mouse model of allergic asthma. Toxicol. Appl. Pharmacol. 273, 19–26.
Rocha, J.D.B., Decoté-Ricardo, D., Redner, P., Lopes, U.G., Barbosa-Filho, J.M., Piuvezam, M.R., 2010. Inhibitory effect of the alkaloid warifteine purified from Cissampelos sympodialis on B lymphocyte function in vitro and in vivo. Planta Med. 76, 325–330.
Sin, B., Togias, A., 2011. Pathophysiology of allergic and nonallergic rhinitis. Proc. Am. Thorac. Soc. 8, 106–114.
Stokes, J.R., Romero, F.A., Allan, R.J., Phillips, P.G., Hackman, F., Misfeldt, J., 2012. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms. J. Allergy Clin. Immunol. 129, 409–412.
Storms, W.W., Segall, N., Mansfield, L.E., Amar, N.J., Kelley, L., Ding, Y., 2013. Efficacy and safety of beclomethasone dipropionate nasal aerosol in pediatric patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 111, 408–414.
Takahashi, Y., Kagawa, Y., Izawa, K., Ono, R., Akagi, M., Kamei, C., 2009. Effect of histamine H4 receptor antagonist on allergic rhinitis in mice. Int. Immunopharmacol. 9, 734–738.
The, B.S., Seow, W.K., Li, S.Y., Thong, Y.H., 1990. Inhibition of prostaglandin and leukotriene generation by the plant alkaloids tetrandrine and berbamine. Int. J. Immunopharmacol. 12, 321–327.
Thakare, V.N., Osama, M.M., Naik, S.R., 2013. Therapeutic potential of curcumin in experimentally induced allergic rhinitis in guinea pigs. Int. Immunopharmacol. 17, 18–25.
Thomas, G., Araújo, C.C., Duarte, J.C., de Souza, D.P., 1997. Bronchodilator activity of an aqueous fraction of an ethanol extract of the leaves of Cissampelos sympodialis Eichl. (Menispermaceae) in the guinea pig. Phytomedicine 4, 233–238.
Tranquilli, W.J., Thurmon, J.C., Grimm, K.A., 2007. Lumb and Jones’ veterinary anesthesia and analgesia. Vet. J. 176, 795–800.
Véron, J., 2015. Repères démographiques 1945–2015. Popul. Soc. 526, 200–206.
Vieira, G.C., de Lima, J.F., de Figueiredo, R.C.B.Q., Mascarenhas, S.R., Bezerra-Santos, C.R., Piuvezam, M.R., 2013. Inhaled Cissampelos sympodialis down-regulates airway allergic reaction by reducing lung CD3+T cells. Phyther. Res. 27, 916–925.
Wang, M., Zhang, W., Shang, J., Yang, J., Zhang, L., Bachert, C., 2013. Immunomodulatory effects of IL-23 and IL-17 in a mouse model of allergic rhinitis. Clin. Exp. Allergy 43, 956–966.
PTB and MRP designed the study, supervised the laboratory work and contributed to critical reading of the manuscript. GCV, FAAFG, RFP and LKDPF were responsible for execution of the project and conducted data analysis and drafted the paper. JMBF gave warifteine for the study. All the authors reviewed and approved the manuscript.
About this article
Cite this article
Vieira, G.C., Gadelha, F.A.A.F., Pereira, R.F. et al. Warifteine, an alkaloid of Cissampelos sympodialis, modulates allergic profile in a chronic allergic rhinitis model. Rev. Bras. Farmacogn. 28, 50–56 (2018). https://doi.org/10.1016/j.bjp.2017.10.009
- Allergic rhinitis
- Nasal tissues
- Mast cells